Emerging Bone Problems in Patients Infected with Human Immunodeficiency Virus

Mondy, Kristin; Tebas, Pablo
April 2003
Clinical Infectious Diseases;4/2/2003 Supplement 2, Vol. 36, pS101
Academic Journal
Recently, a high incidence of osteopenia and osteoporosis has been observed in individuals infected with human immunodeficiency virus (HIV). This problem appears to be more frequent in patients receiving potent antiretroviral therapy. Other bone-related complications in HIV-infected individuals, including avascular necrosis of the hip and compression fracture of the lumbar spine, have also been reported. People living with HIV have significant alterations in bone metabolism, regardless of whether they are receiving potent antiret-roviral therapy. The underlying mechanisms to account for these observations remain unknown, although studies are underway to examine the relationship between the bone abnormalities and other complications associated with HIV and antiretroviral therapy. HIV-infected patients with osteopenia or osteoporosis should be treated similarly to HIV-seronegative patients with appropriate use of nutritional supplements (calcium and vitamin D) and exercise. Hormone replacement and antiresorptive therapies might be also indicated.


Related Articles

  • Osteoporosis a preventable menopausal concern. BASSENT, YVETTE // Charlotte Post;10/6/2011, Vol. 37 Issue 4, p1B 

    The article offers information on the manifestation of osteoporosis and osteopenia among menopausal women and how they can be prevented.

  • Using BMD measurements to define osteopenia and osteoporosis.  // Contemporary OB/GYN;Oct2001, Vol. 46 Issue 10, p54 

    Deals with the use of bone mineral density measurements to determine osteopenia or osteoporosis in a patient. Definitions of the T-score and Z-score; T-score of a person with osteopenia; Implication of a T-score of negative 2.5 or below.

  • Bisphosphonate therapy can reduce bone loss and raise bone mass in renal transplant patients.  // Kidney;Sep/Oct2002, Vol. 11 Issue 5, p224 

    Presents a summary of the study 'Treatment of Osteoporosis and Osteopenia in Long-Term Renal Transplant Patients With Alendronate,' by D.N. Cruz et al., from a 2002 issue the 'American Journal of Transplantation.'

  • High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Klaus, J.; Armbrecht, G.; Steinkamp, M.; Brückel, J.; Rieber, A.; Adler, G.; Reinshagen, M.; Felsenberg, D.; von Tirpitz, C. // Gut;Nov2002, Vol. 51 Issue 5, p654 

    Background and aims: Osteopenia and osteoporosis are frequent in Crohn's disease. However, there are few data on related vertebral fractures. Therefore, we evaluated prospectively the prevalence of osteoporotic vertebral fractures in these patients. Methods: A total of 293 patients were screened...

  • OSTEOPENIA AND OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN. Celiktas, M.; Kozanoglu, E.; Aikimbaev, K.S.; Soyupak, S.; Binokay, F. // Acta Radiologica;Nov2002, Vol. 43 Issue 6, p609 

    Purpose: To compare the ability of the medial cortical thickness ratio to the width of the second metacarpal bone at the midshaft (MCR) in discriminating patients as normal, osteopenic or osteoporotic. Material and Methods: MCR was calculated from radiographs of 120 postmenopausal women. By...

  • A life-long antiretroviral treatment of congenital HIV disease, associated with a mixed fat redistribution syndrome and osteopenia already occurred during pre-pubertal age. Manfredi, Roberto; Calza, Leonardo; Chiodo, Francesco // International Journal of STD & AIDS;Jul2002, Vol. 13 Issue 7, p504 

    An extraordinarily rare case report of mixed fat redistribution syndrome associated with osteopenia but not with relevant metabolic abnormalities is documented in a prepubertal child with congenital HIV infection treated with antiretroviral therapy since the age of six months, up to the present...

  • Treatable Bone Loss Often Goes Undetected.  // Environmental Nutrition;Jan2002, Vol. 25 Issue 1, p1 

    Focuses on the low classification and identification of osteoporosis in United States. Prediction of fracture risk; Prescription of effective drugs, supplements and exercise; Concerns on the development of osteopenia.

  • Crohn's disease linked to vertebral fractures. Dragon, Natalie // GP: General Practitioner;10/28/2002, p7 

    Focuses on a German study regarding the link of Crohn's disease and low bone mass with vertebral fractures. Sample size of the study; Risk of fractures in patients with normal bone density; Estimation of presence of fractures in patients with osteoporosis and osteopenia.

  • OSTEOPENIA AND OSTEOPOROSIS INDICATORS. LEVIN, SUSANNA; Sego, Sherril // Clinical Advisor;Apr2011, Vol. 14 Issue 4, p102 

    The article provides an answer to a question on bisphosphonate therapy which indicates osteoporosis by an axial bone densitometry with >105 score while osteopenia is defined as bone mineral density (BMD).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics